DNLINasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Denali Therapeutics Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$18.04+0.43 (+2.44%)
Close on Oct 19, 2026
- Market cap
- $3.38B
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Denali Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 6, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 6, 2026 | Aug 6, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 27, 2026 | Jul 28, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 12, 2026 | Jun 18, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 3, 2026 | Jun 4, 2026 | SEC EDGAR |
| Current report | 8-K | May 21, 2026 | May 22, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 7, 2026 | SEC EDGAR |
| Current report | 8-K | May 7, 2026 | May 7, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Dec 31, 2025 | Apr 21, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 3, 2026 | Apr 3, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 27, 2026 | Mar 31, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 25, 2026 | Mar 25, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Feb 26, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 26, 2026 | Feb 26, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 6, 2026 | Jan 6, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 9, 2025 | Dec 10, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 4, 2025 | Dec 4, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 4, 2025 | Dec 4, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 6, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 6, 2025 | Nov 6, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 13, 2025 | Oct 14, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 11, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 11, 2025 | Aug 11, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 7, 2025 | Jul 7, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 3, 2025 | Jun 3, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 6, 2025 | SEC EDGAR |
| Current report | 8-K | May 6, 2025 | May 6, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Dec 31, 2024 | Apr 17, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 2, 2025 | Apr 2, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 5, 2025 | Mar 5, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 27, 2025 | Feb 27, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Feb 27, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 13, 2025 | Jan 13, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 6, 2025 | Jan 7, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 12, 2024 | Nov 18, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 6, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 6, 2024 | Nov 6, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 10, 2024 | Oct 10, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 1, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 1, 2024 | Aug 1, 2024 | SEC EDGAR |